Antifungal prophylaxis in leukemia patients

At the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, Antonio Pagliuca, MD from King’s College Hospital, London, UK discusses antifungal prophylaxis in leukemia patients. With therapies focused mainly on disease relapse it is important to remember that morbidity and mortality of fungal disease is significant.

Share this video